Joel C. Marrs

2.4k total citations · 1 hit paper
58 papers, 577 citations indexed

About

Joel C. Marrs is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Joel C. Marrs has authored 58 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Surgery and 15 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Joel C. Marrs's work include Pharmaceutical Practices and Patient Outcomes (14 papers), Lipoproteins and Cardiovascular Health (12 papers) and Blood Pressure and Hypertension Studies (9 papers). Joel C. Marrs is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (14 papers), Lipoproteins and Cardiovascular Health (12 papers) and Blood Pressure and Hypertension Studies (9 papers). Joel C. Marrs collaborates with scholars based in United States, Taiwan and Cyprus. Joel C. Marrs's co-authors include Sarah L. Anderson, Joseph J. Saseen, Alpesh Amin, Kavita Nair, Richard R. Allen, Daniel R. Touchette, Joseph P. Vande Griend, Rebecca Hanratty, Russell E. Glasgow and Stuart T. Haines and has published in prestigious journals such as JAMA, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Joel C. Marrs

55 papers receiving 554 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

American Association of Clinical Endocrinology Clinical Practice Guideline on Pharmacologic Management of Adults With Dyslipidemia

2025 15 citations Joel C. Marrs et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joel C. Marrs United States	16	180	145	135	120	80	58	577
Lucas Van Bortel Belgium	14	159 0.9×	197 1.4×	116 0.9×	65 0.5×	62 0.8×	33	768
Gary Tataronis United States	15	85 0.5×	166 1.1×	87 0.6×	225 1.9×	61 0.8×	24	767
Candice L. Garwood United States	16	246 1.4×	141 1.0×	80 0.6×	66 0.6×	90 1.1×	44	692
Yahaya Hassan Malaysia	13	134 0.7×	201 1.4×	75 0.6×	49 0.4×	43 0.5×	50	630
Beth Bryles Phillips United States	13	297 1.6×	108 0.7×	191 1.4×	75 0.6×	81 1.0×	35	651
Sarah McDowell United Kingdom	14	159 0.9×	213 1.5×	45 0.3×	115 1.0×	59 0.7×	34	835
Donna McLean Canada	11	347 1.9×	141 1.0×	63 0.5×	100 0.8×	125 1.6×	27	564
Jens Bos Netherlands	18	107 0.6×	101 0.7×	98 0.7×	78 0.7×	39 0.5×	74	834
Antonio M. Mendes Brazil	14	77 0.4×	160 1.1×	53 0.4×	62 0.5×	118 1.5×	30	694
Jenifer Wogen United States	12	137 0.8×	64 0.4×	291 2.2×	71 0.6×	67 0.8×	28	714

Countries citing papers authored by Joel C. Marrs

Since Specialization

Citations

This map shows the geographic impact of Joel C. Marrs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel C. Marrs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel C. Marrs more than expected).

Fields of papers citing papers by Joel C. Marrs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel C. Marrs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel C. Marrs. The network helps show where Joel C. Marrs may publish in the future.

Co-authorship network of co-authors of Joel C. Marrs

This figure shows the co-authorship network connecting the top 25 collaborators of Joel C. Marrs. A scholar is included among the top collaborators of Joel C. Marrs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel C. Marrs. Joel C. Marrs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ho, P. Michael, Thomas J. Glorioso, Larry A. Allen, et al.. (2024). Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications. JAMA. 333(1). 49–49. 7 indexed citations

Hosokawa, Patrick, Larry A. Allen, Pamela N. Peterson, et al.. (2024). Abstract 4140970: Association Between Prescription Fill Rates and Adverse Outcomes within an mHealth Clinical Trial Designed to Improve Medication Adherence. Circulation. 150(Suppl_1).

Marrs, Joel C. & Sarah L. Anderson. (2024). Inclisiran for the treatment of hypercholesterolaemia. Drugs in Context. 13. 1–9. 2 indexed citations

Touchette, Daniel R., et al.. (2023). Research and scholarly methods: Measuring medication adherence. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 6(4). 416–426. 26 indexed citations

Marrs, Joel C., et al.. (2023). Description of patient questions received by clinical pharmacists in the Nudge Study. American Journal of Health-System Pharmacy. 80(18). 1247–1254. 2 indexed citations

Karalis, Dean G., et al.. (2022). Impact of telehealth on the current and future practice of lipidology: a scoping review. Journal of clinical lipidology. 17(1). 40–54. 9 indexed citations

Marrs, Joel C., et al.. (2021). Impact of Self-Measured Blood Pressure Monitoring on Hypertension Control. 4(2). 1 indexed citations

Glasgow, Russell E., Christopher E. Knoepke, David J. Magid, et al.. (2021). The NUDGE trial pragmatic trial to enhance cardiovascular medication adherence: study protocol for a randomized controlled trial. Trials. 22(1). 528–528. 22 indexed citations

Marrs, Joel C. & Sarah L. Anderson. (2020). Bempedoic acid for the treatment of dyslipidemia. Drugs in Context. 9. 1–9. 27 indexed citations

10.

Marrs, Joel C. & Sarah L. Anderson. (2020). Ertugliflozin in the treatment of type 2 diabetes mellitus. Drugs in Context. 9. 1–10. 18 indexed citations

11.

Anderson, Sarah L. & Joel C. Marrs. (2019). Can Direct Oral Anticoagulants Be Used for Stroke Prevention Among Patients with Valvular Atrial Fibrillation?. Current Cardiology Reports. 21(10). 118–118. 2 indexed citations

12.

Anderson, Sarah L. & Joel C. Marrs. (2018). Sacubitril/valsartan: evaluation of safety and efficacy as an antihypertensive treatment. Drugs in Context. 7. 1–7. 10 indexed citations

13.

Anderson, Sarah L. & Joel C. Marrs. (2018). A Review of the Role of the Pharmacist in Heart Failure Transition of Care. Advances in Therapy. 35(3). 311–323. 47 indexed citations

14.

Bratberg, Jeffrey, et al.. (2017). The Report of the 2016-2017 Advocacy Standing Committee. American Journal of Pharmaceutical Education. 81(8). S10–S10. 4 indexed citations

15.

Anderson, Sarah L. & Joel C. Marrs. (2017). Antihyperglycemic Medications and Cardiovascular Risk Reduction. touchREVIEWS in Endocrinology. 13(2). 86–86. 9 indexed citations

16.

Marrs, Joel C., et al.. (2015). Evaluation of Statin Prescribing for Secondary Prevention in Primary Care Following New Guideline Recommendations. Annals of Pharmacotherapy. 50(1). 17–21. 11 indexed citations

17.

Anderson, Sarah L., et al.. (2014). Evaluation of Aspirin Use in Patients With Diabetes Receiving Care in Community Health. Annals of Pharmacotherapy. 49(2). 170–177. 1 indexed citations

18.

Anderson, Sarah L. & Joel C. Marrs. (2013). Probable Interaction Between Warfarin and Divalproex Sodium. Journal of Pharmacy Technology. 30(1). 8–12. 2 indexed citations

19.

Marrs, Joel C. & Joseph J. Saseen. (2010). Effects of Lipid‐Lowering Therapy on Reduction of Cardiovascular Events in Patients with End‐Stage Renal Disease Requiring Hemodialysis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(8). 823–829. 9 indexed citations

20.

Marrs, Joel C. & Joseph J. Saseen. (2008). Dyslipidemia Control in Indigent Patients Receiving Medication Assistance Compared with Insured Patients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(5). 562–569. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact